<table id="_RefID5987D02763B443F6A1C8A223DD6FB78F" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 4 Other Potentially Significant Drug Interactions</caption>
<col width="32%"></col>
<col width="33%"></col>
<col width="35%"></col>
<tbody>
<tr>
<td align="center" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>
<content stylecode="bold">Concomitant Drug Class or Food</content>
</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>
<content stylecode="bold">Noted or Anticipated Outcome</content>
</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>
<content stylecode="bold">Clinical Comment</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>
<content stylecode="bold">HMG-Co A Reductase Inhibitors:</content>
<br/>atorvastatin, fluvastatin, lovastatin, pravastatin, simvastatin</paragraph>
</td>
<td rowspan="3" stylecode="Rrule Lrule Botrule ">
<paragraph>Pharmacokinetic and/or pharmacodynamic interaction: the addition of one drug to a stable long-term regimen of the other has resulted in myopathy and rhabdomyolysis (including a fatality)</paragraph>
<paragraph>P-gp substrate; rhabdomyolysis has been reported</paragraph>
</td>
<td rowspan="2" stylecode="Rrule Lrule Botrule ">
<paragraph>Weigh the potential benefits and risks and carefully monitor patients for any signs or symptoms of muscle pain, tenderness, or weakness, particularly during initial therapy; monitoring CPK (creatine phosphokinase) will not necessarily prevent the occurrence of severe myopathy.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>
<content stylecode="bold">Other Lipid-Lowering Drugs: </content>
<br/>fibrates, gemfibrozil</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule Lrule ">
<paragraph>
<content stylecode="bold">Digitalis Glycosides:</content>
<br/>digoxin</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule "></td>
</tr>
</tbody>
</table>